Vir Biotechnology stock hits 52-week high at 12.19 USD
What it means
- What to watch: Good trial results are only step one; approval timing and pricing decide how much it is worth.
- How the stock is trading: $VIR +10.39% in the latest session.
- Timing: It dropped mid-session, while New York was open, so the move beside it may already include the market's first reaction.
Where the stock stands
$VIR last traded at $12.17, +10.39% on the session. That puts it 1.1% shy of its 52-week high of $12.30 and 153% clear of its low of $4.82 — within a tenth of its 52-week high. Over the year it has ranged 155% from low to high: a very wide band; big swings are routine for this one, not news. These are latest-session quotes, not live prices — the live tape is on the $VIR page.
How much coverage it is getting
Nothing else on $VIR in the last 30 days: this is the only story Wook has filed, so there is no run to measure it against yet. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. On Wook's supply-chain scanner, Health Care reads watch today — early signs of strain worth keeping an eye on.
What to watch next
The $VIR page has the full chart, the filings and the valuation model behind every figure here. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. And Wook AI, up top, will happily do the math — how far $VIR sits from its high, or how this week's coverage stacks up.
How this analysis was made
Investing.com published it, and Wook filed it under Healthcare & Pharma. It reads bullish at medium severity because of “high” in the wording, with nothing on the bearish side to offset it. It was matched to $VIR. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on November 6, 2026. $VIR has moved -0.29% ($12.20 to $12.16). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.